Special Issue “Novel Therapeutic Targets in Cancers: 3rd Edition”
International Journal of Molecular Sciences · 11.06.2026 · 27 (12) · 5288
DOI: 10.3390/ijms27125288 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.06.2026. Verfasst von Elena Levantini und 1 weiteren Autor:innen. Beteiligte Einrichtung: CNR-Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche (ITB-CNR), Area della Ricerca di Pisa, 56124 Pisa, PI, Italy. Hauptthemen laut MEDLINE: Neoplasms, Molecular Targeted Therapy, Antineoplastic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer remains one of the most complex and adaptive diseases in clinical medicine, characterized by remarkable genetic and functional heterogeneity across patients, tumor types, and even within individual lesions [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CNR-Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche (ITB-CNR), Area della Ricerca di Pisa, 56124 Pisa, PI, Italy.
- Fondazione Pisana per la Scienza ONLUS (FPS), 56017 San Giuliano Terme, PI, Italy.
ORCID-Profile: Elena Levantini, Giorgia Maroni
Zitieren
APA
Levantini, E., & Maroni, G. (2026). Special Issue “Novel Therapeutic Targets in Cancers: 3rd Edition”. International Journal of Molecular Sciences, 27(12), 5288. https://doi.org/10.3390/ijms27125288
Vancouver
Levantini E, Maroni G. Special Issue “Novel Therapeutic Targets in Cancers: 3rd Edition”. International Journal of Molecular Sciences. 2026;27(12):5288. doi:10.3390/ijms27125288
BibTeX
@article{Levantini2026,
author = {Levantini, Elena and Maroni, Giorgia},
title = {Special Issue “Novel Therapeutic Targets in Cancers: 3rd Edition”},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5288},
doi = {10.3390/ijms27125288}
}
EUVIMED